Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
77 hedge funds and large institutions have $13.3M invested in Surgalign Holdings, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 17 closing their positions.
1,800% more call options, than puts
Call options by funds: $76K | Put options by funds: $4K
69% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 13
29% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 17
7% more funds holding
Funds holding: 72 → 77 (+5)
43% less capital invested
Capital invested by funds: $23.3M → $13.3M (-$9.93M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.74M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.06M |
| 3 |
D.E. Shaw & Co
New York
|
+$517K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$452K |
| 5 |
Renaissance Technologies
New York
|
+$301K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$611K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$590K |
| 3 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$509K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$238K |
| 5 |
VF
Virtu Financial
New York
|
-$226K |
SRGA Hedge Fund Activity: Q1 2022 in Review
77 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q1 2022, worth a combined $13.3M — down 43% from $23.3M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new SRGA positions and 17 closed out — a net gain of 5 holders — while 22 added to existing stakes and 13 trimmed.
The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $3.74M. The largest seller was Dimensional Fund Advisors, cutting an estimated $611K.
- 77 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q1 2022, up from 72 in Q4 2021.
- Funds reported $13.3M of Surgalign Holdings, Inc. Common Stock stock for Q1 2022, down 43% quarter-over-quarter.
- 22 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q1 2022 and 17 closed out, a net change of +5 holders.
- The largest Surgalign Holdings, Inc. Common Stock buyer in Q1 2022 was Stonepine Capital Management, an estimated $3.74M added.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q1 2022 was Dimensional Fund Advisors, an estimated $611K sold.
Based on aggregated 13F filings for Q1 2022.